Letters
Article from Clinical Evidence
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7334.428 (Published 16 February 2002) Cite this as: BMJ 2002;324:428
Cochrane review on IV β2 agonists for acute asthma was not mentioned
- Lars Christian Laursen (lclaursen@dadlnet.dk), doctor
- Department of Lung Diseases, KAS Gentofte, 2900 Hellerup, Denmark
EDITOR—In the article from Clinical Evidence on acute asthma, FitzGerald claims that the effectiveness of intravenous versus nebulised delivery of short acting β2 agonists for acute asthma remains unknown.1 This statement is based on the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.